Arimura T, Hayashi T, Kimura A
Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Acta Myol. 2007 Dec;26(3):153-8.
Idiopathic cardiomyopathy (ICM) is a primary cardiac disorder associated with abnormalities of ventricular wall thickness, size of ventricular cavity, contraction, relaxation, conduction and rhythm. Over the past two decades, molecular genetic analyses have revealed that mutations in the various genes cause ICM and such information concerning the genetic basis of ICM enables us to speculate the pathogenesis of this heterogeous cardiac disease. This review focuses on the molecular pathogenesis, i.e., genetic abnormalities and functional alterations due to the mutations especially in sarcomere/cytoskeletal components, in three characteristic features of ICM, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). Understanding the functional abnormalities of the sarcomere/cytoskeletal components, in ICM, has unraveled the function of these components not only as a contractile unit but also as a pivot for transduction of biochemical signals.
特发性心肌病(ICM)是一种原发性心脏疾病,与心室壁厚度、心室腔大小、收缩、舒张、传导及节律异常有关。在过去二十年中,分子遗传学分析表明,各种基因的突变会导致ICM,而这些有关ICM遗传基础的信息使我们能够推测这种异质性心脏疾病的发病机制。本综述聚焦于ICM三个特征性类型,即肥厚型心肌病(HCM)、扩张型心肌病(DCM)和限制型心肌病(RCM)的分子发病机制,即尤其是肌节/细胞骨架成分中的突变所导致的基因异常和功能改变。了解ICM中肌节/细胞骨架成分的功能异常,不仅揭示了这些成分作为收缩单位的功能,还揭示了它们作为生化信号转导枢纽的功能。